2009
DOI: 10.1016/j.ejon.2008.11.005
|View full text |Cite
|
Sign up to set email alerts
|

Breast cancer follow up: A randomised controlled trial comparing point of need access versus routine 6-monthly clinical review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
113
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 61 publications
(119 citation statements)
references
References 17 publications
2
113
0
Order By: Relevance
“…In breast cancer, recent trials have compared traditional follow-up with alternatives, including their acceptability and satisfaction to patients, their impact on quality of life, and any lack of disadvantage in detection of recurrence [28,29]. Giving patients the option to initiate their own contact with specialist nurses based on self-assessed need is a growing trend [29,30,34,39,44].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…In breast cancer, recent trials have compared traditional follow-up with alternatives, including their acceptability and satisfaction to patients, their impact on quality of life, and any lack of disadvantage in detection of recurrence [28,29]. Giving patients the option to initiate their own contact with specialist nurses based on self-assessed need is a growing trend [29,30,34,39,44].…”
Section: Discussionmentioning
confidence: 99%
“…Giving patients the option to initiate their own contact with specialist nurses based on self-assessed need is a growing trend [29,30,34,39,44]. In the main, there is high satisfaction with patient-led follow-up by low to moderate risk breast cancer survivors, as long as they are confident to assess their own symptoms, have a clear indication of their future risk profile, receive annual mammographic surveillance, and are provided with a safe, reliable, and quick route back to specialist care if needed.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Of these purposes, the early detection of new primary cancer or locoregional recurrence help improve the survival rate, but the diagnosis of distant metastasis is known to have no advantage in survival rate or health-related quality of life (QoL) [4,5]. Also, randomized controlled trials have found that reduced follow-up strategies did not negatively affect patient outcomes or early detection of recurrence, and more intensive follow-up was associated with higher costs without differences in early detection of relapses [6,7]. …”
Section: Introductionmentioning
confidence: 99%